MH administration exerted neuroprotective effect against memory impairment and improved locomotor activity in rodents via inhibition of oxidative stress markers/release of proinflammatory cytokines and suppression of protein expression of NF-kB/TLR4/NLRP3. The gene discussed is NLRP3; the disease is memory impairment.